What is Global Drug Developing Platforms by Artificial Intelligence (AI) Market?
The Global Drug Developing Platforms by Artificial Intelligence (AI) Market is a revolutionary concept that is transforming the pharmaceutical industry. It refers to the use of AI technology in the development of new drugs, from the initial stages of research and discovery to the final stages of clinical trials and market release. This innovative approach leverages the power of AI to analyze vast amounts of data, identify potential drug candidates, predict their effectiveness and safety, and accelerate their development process. The goal is to improve the efficiency and success rate of drug development, reduce costs, and ultimately bring more effective and safer drugs to the market faster. This market is driven by the increasing demand for new drugs, the growing complexity of drug development, and the advancements in AI technology. It is also supported by the increasing investment in AI by pharmaceutical companies and the growing collaboration between tech companies and pharmaceutical companies.
Software, System, Service, Product, Others in the Global Drug Developing Platforms by Artificial Intelligence (AI) Market:
The Global Drug Developing Platforms by Artificial Intelligence (AI) Market is segmented into Software, System, Service, Product, and Others. The Software segment includes AI software used in drug development, such as machine learning algorithms, predictive analytics tools, and data mining tools. The System segment includes AI systems used in drug development, such as robotic systems, automated lab systems, and AI-powered research platforms. The Service segment includes AI services provided by tech companies to pharmaceutical companies, such as AI consulting, AI training, and AI implementation services. The Product segment includes AI-powered products used in drug development, such as AI-powered drug discovery platforms, AI-powered clinical trial platforms, and AI-powered drug testing platforms. The Others segment includes other AI technologies used in drug development, such as AI-powered imaging tools, AI-powered genomics tools, and AI-powered biomarker discovery tools. Each of these segments plays a crucial role in the AI-driven drug development process, contributing to the efficiency, accuracy, and speed of drug development.
Generate Data and Models, Repurpose Existing Drugs, Generate Novel Drug Candidates, Validate and Optimize Drug Candidates, Design Drugs, Others in the Global Drug Developing Platforms by Artificial Intelligence (AI) Market:
The Global Drug Developing Platforms by Artificial Intelligence (AI) Market is used in various areas of drug development. In the Generate Data and Models area, AI is used to generate and analyze large amounts of data, build predictive models, and identify potential drug candidates. In the Repurpose Existing Drugs area, AI is used to analyze existing drugs, identify new uses for them, and accelerate their repurposing process. In the Generate Novel Drug Candidates area, AI is used to analyze biological data, identify novel drug targets, and generate novel drug candidates. In the Validate and Optimize Drug Candidates area, AI is used to validate the effectiveness and safety of drug candidates, optimize their properties, and accelerate their development process. In the Design Drugs area, AI is used to design new drugs, predict their properties, and accelerate their design process. In the Others area, AI is used in other aspects of drug development, such as clinical trial design, patient recruitment, and drug marketing.
Global Drug Developing Platforms by Artificial Intelligence (AI) Market Outlook:
The outlook for the Global Drug Developing Platforms by Artificial Intelligence (AI) Market is promising. The global pharmaceutical market, which is currently valued at 1475 billion USD in 2022, is expected to grow at a compound annual growth rate (CAGR) of 5% over the next six years. This growth is driven by the increasing demand for new drugs, the growing complexity of drug development, and the advancements in AI technology. Meanwhile, the chemical drug market is projected to increase from 1005 billion in 2018 to 1094 billion U. S. dollars in 2022. This growth is driven by the increasing demand for chemical drugs, the advancements in chemical drug development, and the growing investment in chemical drug research. These trends indicate a positive outlook for the AI-driven drug development market, with increasing opportunities for AI technology in the pharmaceutical industry.
| Report Metric | Details |
| Report Name | Drug Developing Platforms by Artificial Intelligence (AI) Market |
| CAGR | 5% |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM, Microsoft, Google, AiCure, Calico, Iktos, GNS Healthcare, Genpact, Biovista, NuMedii, BenevolentAI, BERG, Schrödinge, Nuritas, Exscientia, Kairntech, Concerto HealthAI (SymphonyAI), NVIDIA Corporation, Sirenas, Standigm, Transcriptic, Cloud Pharmaceuticals, Cyclica |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
